These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 10919884)

  • 41. What is the significance of vortex vein invasion in uveal melanoma?
    Raoof N; Rennie IG; Salvi SM; Sisley K; Caine A; Mudhar HS
    Eye (Lond); 2009 Aug; 23(8):1661-7. PubMed ID: 19011609
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Uveal melanoma in teenagers and children. A report of 40 cases.
    Shields CL; Shields JA; Milite J; De Potter P; Sabbagh R; Menduke H
    Ophthalmology; 1991 Nov; 98(11):1662-6. PubMed ID: 1800926
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Combined Effects of Yttrium-90 Transarterial Radioembolization around Immunotherapy for Hepatic Metastases from Uveal Melanoma: A Preliminary Retrospective Case Series.
    Zheng J; Irani Z; Lawrence D; Flaherty K; Arellano RS
    J Vasc Interv Radiol; 2018 Oct; 29(10):1369-1375. PubMed ID: 30174161
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Transarterial chemoembolization with drug-eluting beads preloaded with irinotecan as a first-line approach in uveal melanoma liver metastases: tumor response and predictive value of diffusion-weighted MR imaging in five patients.
    Venturini M; Pilla L; Agostini G; Cappio S; Losio C; Orsi M; Ratti F; Aldrighetti L; De Cobelli F; Del Maschio A
    J Vasc Interv Radiol; 2012 Jul; 23(7):937-41. PubMed ID: 22720894
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A multireferral centre retrospective cohort analysis on the experience in treatment of metastatic uveal melanoma and utilization of sequential liver-directed treatment and immunotherapy.
    Itchins M; Ascierto PA; Menzies AM; Oatley M; Lo S; Douraghi-Zadeh D; Harrington T; Maher R; Grimaldi AM; Guminski A
    Melanoma Res; 2017 Jun; 27(3):243-250. PubMed ID: 28230715
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Clinical presentation, pathological features and natural course of metastatic uveal melanoma, an orphan and commonly fatal disease.
    Cerbone L; Van Ginderdeuren R; Van den Oord J; Fieuws S; Spileers W; Van Eenoo L; Wozniak A; Sternberg CN; Schöffski P
    Oncology; 2014; 86(3):185-9. PubMed ID: 24776955
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Metastatic melanoma in the eye and orbit.
    Zografos L; Ducrey N; Beati D; Schalenbourg A; Spahn B; Balmer A; Othenin-Girard CB; Chamot L; Egger E
    Ophthalmology; 2003 Nov; 110(11):2245-56. PubMed ID: 14597536
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Risk-stratified systemic surveillance in uveal melanoma.
    Davanzo JM; Binkley EM; Bena JF; Singh AD
    Br J Ophthalmol; 2019 Dec; 103(12):1868-1871. PubMed ID: 30705044
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Uveal melanoma and pregnancy. A report of 16 cases.
    Shields CL; Shields JA; Eagle RC; De Potter P; Menduke H
    Ophthalmology; 1991 Nov; 98(11):1667-73. PubMed ID: 1800927
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Hepatic metastasis from uveal melanoma: angiographic pattern predictive of survival after hepatic arterial chemoembolization.
    Dayani PN; Gould JE; Brown DB; Sharma KV; Linette GP; Harbour JW
    Arch Ophthalmol; 2009 May; 127(5):628-32. PubMed ID: 19433711
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Uveal melanoma: the challenge to save more lives].
    Barrio Barrio J
    Arch Soc Esp Oftalmol; 2005 Nov; 80(11):629-30. PubMed ID: 16311949
    [No Abstract]   [Full Text] [Related]  

  • 52. [Advances in uveal melanoma].
    Piperno-Neumann S; Desjardins L
    Rev Prat; 2014 Jan; 64(1):83-4. PubMed ID: 24649554
    [No Abstract]   [Full Text] [Related]  

  • 53. Prognostic factors of liver metastases from uveal melanoma.
    Kodjikian L; Grange JD; Baldo S; Baillif S; Garweg JG; Rivoire M
    Graefes Arch Clin Exp Ophthalmol; 2005 Oct; 243(10):985-93. PubMed ID: 15891893
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Characterization of computed tomography scan abnormalities in patients with biopsy-proven hepatic metastases from uveal melanoma.
    Patel M; Winston CB; Marr BP; Carvajal RD; Schwartz GK; Wolchok J; Busam K; Abramson DH
    Arch Ophthalmol; 2011 Dec; 129(12):1576-82. PubMed ID: 22159677
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Latest developments in the biology and management of uveal melanoma.
    Patel SP
    Curr Oncol Rep; 2013 Dec; 15(6):509-16. PubMed ID: 24122445
    [No Abstract]   [Full Text] [Related]  

  • 56. A prognostic model and staging for metastatic uveal melanoma.
    Eskelin S; Pyrhönen S; Hahka-Kemppinen M; Tuomaala S; Kivelä T
    Cancer; 2003 Jan; 97(2):465-75. PubMed ID: 12518371
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Radioembolization as salvage therapy for hepatic metastasis of uveal melanoma: a single-institution experience.
    Gonsalves CF; Eschelman DJ; Sullivan KL; Anne PR; Doyle L; Sato T
    AJR Am J Roentgenol; 2011 Feb; 196(2):468-73. PubMed ID: 21257902
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Interleukin-2 therapy for metastatic uveal melanoma.
    Dorval T; Fridman WH; Mathiot C; Pouillart P
    Eur J Cancer; 1992; 28A(12):2087. PubMed ID: 1419309
    [No Abstract]   [Full Text] [Related]  

  • 59. Mortality from uveal melanoma treated by enucleation --a 16-year survey in Taiwan.
    Liu YC; Tsai CC; Lee FL; Lee SM; Kao SC
    Acta Ophthalmol; 2013 Nov; 91(7):e583-4. PubMed ID: 24131706
    [No Abstract]   [Full Text] [Related]  

  • 60. Uveal melanoma prognostication: from lesion size and cell type to molecular class.
    Gill HS; Char DH
    Can J Ophthalmol; 2012 Jun; 47(3):246-53. PubMed ID: 22687301
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.